| Application no. and date | 21718158.5 (espacenet) (Federated) (European Patent Register), 20210419 | | Patent/reg. no. and date | DK/EP 4135756, 20240327 | | Publication date | 20230222 | | Priority no. and date | US 202063011738 P, 20200417, EP 20170253, 20200417 | | EP pub. no. and date |
EP 4135756 20230222 | | Effective date | | | Applicant/owner | Pharming Intellectual Property B.V., Darwinweg 24
2333 CR Leiden, NL | | Applicant ref. no. | V474719DK00 | | Inventor | GIANNETTI, Bruno, Darwinweg 24
2333 CR Leiden, NL,
RELAN, Anurag, Darwinweg 24
2333 CR Leiden, NL,
SCHAALE-MAASS, Juergen Ulrich, Darwinweg 24
2333 CR Leiden, NL | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 38/57 (2006.01) , A61P 11/00 (2006.01) , A61P 31/12 (2006.01) , A61P 31/14 (2006.01) , A61P 31/16 (2006.01) , C07K 14/44 (2006.01) , C07K 14/81 (2006.01) | | Title | C1-esteraseinhibitor til at behandle åndedrætsbesvær relateret til en coronavirusinfektion | | Int. application no. | EP2021060098 | | Int. publication no. | WO2021209644 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
